Based on the best nationally representative data available today, about 15% of adult women in the United States are currently using a GLP-1 medication, according to KFF
Even when symptoms improve, the brain may still be healing ongoing care ensures safe, lasting results
Potential Benefits : BPC-157 may provide several potential benefits for IBS symptoms by supporting gut repair, reducing inflammation, and improving digestive function
Youll have one of our licensed medical professionals following your progress, and youll be able to discuss any worries, concerns, or questions you might have during your appointment
Weight Loss Clinical Trial Results In Phase 2 clinical trials: Participants receiving 12 mg experienced up to 24.2% average body weight loss at 48 weeks Additional studies reported up to 28.7% weight reduction at 68 weeks Higher doses (8 mg and 12 mg) demonstrated the most significant results These findings suggest Retatrutide may outperform current GLP-1 therapies and dual-agonist medications in terms of total weight loss